HomeGUD • TSE
add
Knight Therapeutics Inc
Nakaraang pagsara
$5.55
Sakop ng araw
$5.53 - $5.73
Sakop ng taon
$5.09 - $6.23
Market cap
567.27M CAD
Average na Volume
61.29K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 92.26M | 13.21% |
Gastos sa pagpapatakbo | 41.81M | 6.53% |
Net na kita | 85.00K | -99.11% |
Net profit margin | 0.09 | -99.23% |
Kita sa bawat share | — | — |
EBITDA | 16.59M | 13.43% |
Aktuwal na % ng binabayarang buwis | 86.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 172.32M | 7.75% |
Kabuuang asset | 962.29M | -4.83% |
Kabuuang sagutin | 188.38M | -4.12% |
Kabuuang equity | 773.91M | — |
Natitirang share | 100.80M | — |
Presyo para makapag-book | 0.72 | — |
Return on assets | 0.84% | — |
Return on capital | 0.97% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 85.00K | -99.11% |
Cash mula sa mga operasyon | 5.02M | -66.93% |
Cash mula sa pag-invest | 11.53M | -67.76% |
Cash mula sa financing | -3.93M | 65.06% |
Net change in cash | 12.95M | -67.28% |
Malayang cash flow | 1.02M | 121.60% |
Tungkol
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Itinatag
2014
Headquarters
Website
Mga Empleyado
725
